Introduction The burden of chronic kidney disease (CKD) is growing rapidly around the
world. However, there is limited information on the overall regional prevalence of CKD, as …

Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …

Background Health system planning requires careful assessment of chronic kidney disease
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non …

Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary
albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated …

Aims To compare the occurrence of cerebral, cardiovascular, and renal events in patients
with hyperuricaemia treated with febuxostat and those treated with conventional therapy with …

Chronic kidney disease, defined as a reduced glomerular filtration rate or increased urinary
albumin excretion, is recognised as a rapidly growing global health burden, and increasing …

Objectives While increasing attention is paid to the rising prevalence of chronic diseases in
Africa, there is little focus on chronic kidney disease (CKD). This systematic review assesses …

Chronic kidney disease (CKD) is a major risk factor for endstage renal disease,
cardiovascular disease, and premature death. Here we estimated the global prevalence and …

Chronic kidney disease is a common disorder and its prevalence is increasing worldwide.
Early diagnosis on the basis of presence of proteinuria or reduced estimated glomerular …